Details for New Drug Application (NDA): 021882
✉ Email this page to a colleague
The generic ingredient in EXJADE is deferasirox. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the deferasirox profile page.
Summary for 021882
Tradename: | EXJADE |
Applicant: | Novartis |
Ingredient: | deferasirox |
Patents: | 0 |
Suppliers and Packaging for NDA: 021882
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EXJADE | deferasirox | TABLET, FOR SUSPENSION;ORAL | 021882 | NDA | Novartis Pharmaceuticals Corporation | 0078-0468 | 0078-0468-15 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0468-15) |
EXJADE | deferasirox | TABLET, FOR SUSPENSION;ORAL | 021882 | NDA | Novartis Pharmaceuticals Corporation | 0078-0469 | 0078-0469-15 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0469-15) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 125MG | ||||
Approval Date: | Nov 2, 2005 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 250MG | ||||
Approval Date: | Nov 2, 2005 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 500MG | ||||
Approval Date: | Nov 2, 2005 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021882
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | EXJADE | deferasirox | TABLET, FOR SUSPENSION;ORAL | 021882-002 | Nov 2, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | EXJADE | deferasirox | TABLET, FOR SUSPENSION;ORAL | 021882-001 | Nov 2, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | EXJADE | deferasirox | TABLET, FOR SUSPENSION;ORAL | 021882-002 | Nov 2, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | EXJADE | deferasirox | TABLET, FOR SUSPENSION;ORAL | 021882-003 | Nov 2, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription